Sponsor Pipeline

The Lymphoma Academic Research Organisation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
18
Active Trials
9
Recruiting
2
Phase 3
6
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT02889523
Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma…
date change Completion pushed: 2026-04 -> 2029-09
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-31 NCT07738887 Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia… Phase 2 Not Yet Recruiting
2026-07-31 NCT07739459 Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 3
2
Phase 2
10
Phase 1/2
2
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06284122 Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy… Follicular Lymphoma Recruiting
NCT06006117 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or… Marginal Zone Lymphoma Recruiting
Phase 2
NCT06271057 Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High… Diffuse Large B-cell Lymphoma Refractory Recruiting
NCT06931652 Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With… Primary CNS Lymphoma (PCNSL) Recruiting
NCT06558604 Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell… Lymphoma, Mantle-Cell Recruiting
NCT04842877 Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory… Lymphoma, B-Cell Active, Not Recruiting
NCT04531046 Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma… B-Cell Lymphoma Refractory Active, Not Recruiting
NCT04802590 Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell… Mantle Cell Lymphoma Active, Not Recruiting
NCT04974216 Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large… DLBCL Active, Not Recruiting
NCT04984837 Study of Lacutamab in Peripheral T-cell Lymphoma Peripheral T Cell Lymphoma Active, Not Recruiting
NCT07738887 Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia… Chronic Lymphocytic Leukemia Not Yet Recruiting
NCT07739459 Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic… Chronic Lymphocytic Leukemia Not Yet Recruiting
Phase 1/2
NCT07018752 A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas Peripheral T Cells Lymphoma (PTCL) Recruiting
NCT02889523 Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma… Lymphoma Active, Not Recruiting
Not specified
NCT04220970 Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL) Recruiting
NCT04328298 French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T) Hematopathology Eligible or CAR-t Cell Treatment Recruiting
NCT06994169 Glofitamab in Real Life Large B-cell Lymphoma Recruiting
NCT07514715 Proof of Concept for Real-time Multicentric Monitoring of MRD by PET and ctDNA in… Aggressive B-cell Lymphomas Not Yet Recruiting
Disease Areas
Get alerts when The Lymphoma Academic Research Organisation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free